340B And Price Negotiation: US Medicare Washes Its Hands Of The Issue

CMS washed its hands of the 340B discount pricing and Medicare price negotiation issue. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Medicare

More from Market Access